Timing of births and oral contraceptive use influences ovarian cancer risk
Open Access
- 27 July 2017
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 141 (12) , 2392-2399
Abstract
Increasing parity and duration of combined oral contraceptive (COC) use provide substantial protection against ovarian carcinoma (cancer). There are limited data on the impact of the age of the births or age of COC use on reducing ovarian cancer risk. Here, we examined the effects of age at first and last births and age at use of COCs using data from studies conducted in Los Angeles County, California, USA (1,632 cases, 2,340 controls). After adjusting for the number of births, every 5 years that a first birth was delayed reduced the risk of ovarian cancer by 13% (95% CI 5–21%; p = 0.003); a first birth after age 35 was associated with a 47% lower risk than a first birth before age 25. COC use before age 35 was associated with greater protection per year of use than COC use at older ages. Considering previously published results as well as the results presented here, increasing parity and a later age at births are both important protective factors against ovarian cancer and the protection extends over 30 or more years from last birth. Current models of the etiology of ovarian cancer do not encompass an effect of late age at births. Our result of an attenuation of the protective effect with COC use after around age 35 needs further investigation as it has not been seen in all studies.Keywords
Funding Information
- National Cancer Institute (CA58598, CA17054)
This publication has 17 references indexed in Scilit:
- Combined and Interactive Effects of Environmental and GWAS-Identified Risk Factors in Ovarian CancerCancer Epidemiology, Biomarkers & Prevention, 2013
- Does the time interval between first and last birth influence the risk of endometrial and ovarian cancer?European Journal of Cancer, 2010
- Hormonal Risk Factors for Ovarian Cancer in Premenopausal and Postmenopausal WomenAmerican Journal of Epidemiology, 2008
- Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23 257 women with ovarian cancer and 87 303 controlsThe Lancet, 2008
- Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control studyFertility and Sterility, 2004
- Risk Factors for Invasive Epithelial Ovarian Cancer: Results from a Swedish Case-Control StudyAmerican Journal of Epidemiology, 2002
- Menstrual and reproductive factors in relation to ovarian cancer riskBritish Journal of Cancer, 2001
- Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studiesThe Lancet, 1996
- Parity, age at first childbirth, and risk of ovarian cancerThe Lancet, 1994
- Characteristics Relating to Ovarian Cancer Risk: Collaborative Analysis of 12 US Case -Control StudiesAmerican Journal of Epidemiology, 1992